SIGA Technologies Inc. Press Release Archive
- 2011-11-08: SIGA Technologies Reports Financial Results for the Third Quarter of 2011
- 2011-09-22: SIGA COMMENTS ON COURT RULING IN PHARMATHENE LITIGATION
- 2011-08-24: SIGA Awarded $7.7 Million Grant for the Development of Antiviral Drugs for Arenaviruses
- 2011-08-01: SIGA Technologies Reports Financial Results for the Second Quarter and First Half of 2011
- 2011-07-26: SIGA TO PARTICIPATE IN GOLDMAN SACHS SMALL CAP HEALTHCARE 1x1 DAY
- 2011-06-27: SIGA TO SELL 1.7 MILLION COURSES OF ST-246® TO NATIONAL STOCKPILE UNDER MODIFIED BARDA CONTRACT
- 2011-05-15: PROTEST FILED AGAINST BARDA OVER SMALLPOX ANTIVIRAL BIODEFENSE CONTRACT
- 2011-05-13: SIGA TECHNOLOGIES AWARDED U.S. GOVERNMENT CONTRACT VALUED AT UP TO $2.8 BILLION
- 2011-05-05: SIGA TECHNOLOGIES REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER 2011
- 2011-03-14: SIGA APPOINTS WILLIAM C. BEVINS AND FRANCES FRAGOS TOWNSEND TO BOARD OF DIRECTORS
- 2011-03-09: SIGA TECHNOLOGIES REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED 2010
- 2011-02-21: NEW SMALLPOX ANTIVIRAL PROCUREMENT COMMENCED
- 2011-02-11: SIGA APPOINTS DANIEL LUCKSHIRE AS CHIEF FINANCIAL OFFICER
- 2010-11-18: SIGA COMMENTS ON U.S. GOVERNMENT SURVEY ON SMALLPOX ANTIVIRAL ACQUISITION
- 2010-11-07: SIGA TO APPEAL ADVERSE SMALL BUSINESS SIZE DETERMINATION
- 2010-11-02: SIGA Technologies Reports Financial Results for the Third Quarter of 2010
- 2010-10-13: SIGA SELECTED FOR THE PROCUREMENT OF SMALLPOX ANTIVIRAL DRUG FOR THE STRATEGIC NATIONAL STOCKPILE AND RESPONDS TO SMALL BUSINESS SIZE PROTEST
- 2010-08-05: SIGA TECHNOLOGIES REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER AND FIRST HALF OF 2010
- 2010-06-23: SIGA COMPLETES FOURTH SUCCESSFUL HUMAN SAFETY CLINICAL TRIAL
- 2010-06-21: Andy Stern Joins SIGA's Board of Directors
- 2010-05-12: SIGA CEO DR. ERIC ROSE ADDRESSES CONGRESSIONAL APPROPRIATIONS SUBCOMMITTEE ON BEHALF OF THE ALLIANCE FOR BIOSECURITY
- 2010-05-04: SIGA TECHNOLOGIES REPORTS OPERATING RESULTS FOR THE FIRST QUARTER OF 2010
- 2010-03-10: SIGA Technologies Reports Financial Results for the Fourth Quarter and Full Year of 2009
- 2010-03-01: SIGA to Participate at RBC Capital Markets and Cowen & Company Healthcare Conferences
- 2010-02-25: SIGA Awarded a $2.8 Million DoD Contract With Additional Options for the Development of a Broad Spectrum Antiviral Drug
- 2010-01-19: Israel Taps SIGA Technologies' ST-246(R) to Combat Smallpox in Simulated Bioterror Attack
- 2009-12-14: SIGA TECHNOLOGIES, INC. ANNOUNCES CLOSE OF $20 MILLION COMMON STOCK OFFERING
- 2009-12-10: SIGA Technologies, Inc. Raises $20.0 Million in a Common Stock Offering
- 2009-11-09: SIGA Technologies Reports Operating Results for the Third Quarter of 2009
- 2009-11-05: SIGA Presents Update on ST-246(R) Development to the World Health Organization
- 2009-10-30: SIGA Technologies Files $100 Million Shelf Registration
- 2009-09-03: SIGA Technologies Inc. Approved for Nasdaq Global Market Listing
- 2009-09-02: SIGA Technologies Receives a $3 Million Research Grant From the National Institute of Health
- 2009-08-06: SIGA Technologies Reports Operating Results For the Second Quarter of 2009
- 2009-06-29: SIGA Reaches Next Stage in BARDA's RFP Bidding Process
- 2009-06-26: SIGA Technologies, Inc. to be Added to the Russell 3000® and Russell Global® Indices
- 2009-06-15: SIGA Completes Nonclinical Toxicology Studies Supporting Safety in Humans for ST-246®
- 2009-06-09: SIGA Proposal to Fund Work on Broad Spectrum Antiviral Selected for Award by Department of Defense
- 2009-05-14: SIGA Technologies Submits Response to BARDA RFP
- 2009-03-30: SIGA Produces FDA Registration Batches of ST-246(r) Drug Product
- 2009-03-12: SIGA to Respond to Barda's Request for Proposal Seeking 1.7 Million Courses of Smallpox Antiviral
- 2009-02-24: ST-246(r) in Combination With the Smallpox Vaccine ACAM2000(tm) Confers Protective Immunity in Primates
- 2009-02-11: BARDA Issues a Presolicitation for Acquisition of a Smallpox Antiviral
- 2009-01-13: SIGA Clarifies European Regulatory Path for Lead Smallpox Anti-viral ST-246
- 2008-12-17: SIGA Completes Manufacture of ST-246 Registration Batches
- 2008-12-02: SIGA Technologies Completes Human Pharmacokinetic Bridging Study Validating Commercial Formulation
- 2008-11-12: SIGA to Present ST-246 to the World Health Organization
- 2008-11-10: SIGA TECHNOLOGIES REPORTS OPERATING RESULTS FOR THE THIRD QUARTER OF 2008
- 2008-11-06: SIGA TECHNOLOGIES TO PRESENT AT THE RODMAN AND RENSHAW ANNUAL GLOBAL INVESTMENT CONFERENCE
- 2008-11-03: SIGA APPLAUDS EFFORTS TO PROMOTE PRIVATE SECTOR PARTICIPATION IN SMALLPOX BIODEFENSE
- 2008-10-23: SIGA TECHNOLOGIES NAMED TO DELOITTE TRI-STATE AREA TECHNOLOGY FAST 50
- 2008-10-15: SIGA TECHNOLOGIES’ ST-246 NAMED “MOLECULE OF THE MONTH†BY PROUS SCIENCE
- 2008-10-14: SIGA to Present At The Homeland Security Investor Conference
- 2008-09-25: SIGA Technologies to Participate in Committee Meeting for the Institute of Medicine
- 2008-09-18: SIGA Technologies to Attend the HHS Public Health Emergency Medical Countermeasures Enterprise Stakeholders Workshop 2008 and BARDA Industry Day
- 2008-09-18: SIGA Technologies Receives Additional $20 Million From NIH for ST-246 Antiviral Therapeutic Development
- 2008-09-15: NIH Funds SIGA Lassa Antiviral Program
- 2008-09-12: NIH Funds SIGA Dengue Antiviral Program
- 2008-08-12: SIGA Technologies Reports Operating Results for the Second Quarter of 2008
- 2008-05-21: SIGA Advances Dengue Antiviral Program